In particular, in terms of glucose metabolism, observed phenotypes such as insulin resistance, abnormal glucose metabolism in the brain, and high blood glucose could be partially attributed to the interplay between MeCP2 and BDNF within RTT pathophysiology. Here, MECP2 is linked to Insulin resistance.